These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9175618

  • 21. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L, Field MJ, Hughes J, Menzies R, Oles RJ, Vass CA, Woodruff GN.
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [Abstract] [Full Text] [Related]

  • 22. Cholecystokinin receptors do not mediate the behavioral effects of lipopolysaccharide in mice.
    Bluthé RM, Michaud B, Kelley KW, Dantzer R.
    Physiol Behav; 1997 Aug; 62(2):385-9. PubMed ID: 9251984
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Attenuation of CCK-induced aversion in rats on the elevated x-maze by the selective 5-HT1A receptor antagonists (+) WAY100135 and WAY100635.
    Bickerdike MJ, Fletcher A, Marsden CA.
    Neuropharmacology; 1995 Jul; 34(7):805-11. PubMed ID: 8532148
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA, Ritter RC.
    Physiol Behav; 1998 Feb 15; 63(4):711-6. PubMed ID: 9523920
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine.
    Alttoa A, Harro J.
    Eur Neuropsychopharmacol; 2004 Aug 15; 14(4):324-31. PubMed ID: 15163443
    [Abstract] [Full Text] [Related]

  • 36. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E, Tatarczyńska E, Chojnacka-Wójcik E.
    Neuropharmacology; 2000 Jul 24; 39(10):1858-64. PubMed ID: 10884566
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN.
    Proc Natl Acad Sci U S A; 1991 Feb 15; 88(4):1130-3. PubMed ID: 1996314
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.